Edges in Network
| Network | GSE18864_top500tf - GSE18864 - SiGN-BN HC+Bootstrap |
| Network Description | Tumor expression data from neoadjuvant trial of cisplatin monotherapy in triple negative breast cancer patients |
| Node | NFATC2 |
| Upstream (Parents) |
|---|
| (<<) ETS1 → NFATC2 |
| (<<) TSHZ2 → NFATC2 |
| (<<) NR3C1 → NFATC2 |
| (<<) MAFB → NFATC2 |
| (<<) IRF6 → NFATC2 |
| (<<) TSHZ1 → NFATC2 |
| (<<) MAF → NFATC2 |
| (<<) EOMES → NFATC2 |
| (<<) FOXO1 → NFATC2 |
| (<<) FOXN3 → NFATC2 |
| Downstream (Children) |
|---|
| NFATC2 → IKZF1 (>>) |
| NFATC2 → IRF1 (>>) |
| NFATC2 → BHLHE41 (>>) |
| NFATC2 → NR2F1 (>>) |
| NFATC2 → RUNX3 (>>) |
| NFATC2 → IRF8 (>>) |
| NFATC2 → ZNF281 (>>) |
| NFATC2 → IRX3 (>>) |
| NFATC2 → CREM (>>) |
| NFATC2 → ZNF131 (>>) |
| NFATC2 → UBP1 (>>) |
| NFATC2 → HOXC9 (>>) |
| NFATC2 → GAS7 (>>) |
| NFATC2 → STAT2 (>>) |
| NFATC2 → NPAT (>>) |
| NFATC2 → E2F6 (>>) |
| NFATC2 → MGA (>>) |
| NFATC2 → MAX (>>) |
| NFATC2 → NR1D2 (>>) |
| NFATC2 → SP140 (>>) |
